Literature DB >> 6685992

Pharmacokinetics of aztreonam in rabbit eyes.

M Barza, M McCue.   

Abstract

Subconjunctival injection of 100 mg of aztreonam in rabbits with Pseudomonas aeruginosa endophthalmitis produced transiently high antibiotic concentrations in most intraocular sites. Concentrations of approximately 2.5 micrograms/ml were achieved in the vitreous humor 15 min after injection and persisted for 6 h. Repeated intramuscular injections in dosages of 25 mg/kg every 4 h resulted in drug concentrations in the vitreous humor of 2.4 micrograms/ml in infected eyes. These levels might be adequate for the treatment of intraocular infections caused by highly susceptible organisms. Direct intravitreal injection of 100 micrograms of aztreonam in normal rabbit eyes produced an estimated peak concentration in the vitreous humor of 62 micrograms/ml, with a half-life of 7.5 h, which declined to 6 micrograms/ml by 48 h. The pharmacokinetic indices suggest that, like other beta-lactam antibiotics, aztreonam is eliminated from the vitreous humor by the retinal route. This novel antibiotic warrants further study of its efficacy and toxicity to determine whether it may be a useful alternative to the aminoglycosides for selected cases of ocular infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6685992      PMCID: PMC185357          DOI: 10.1128/AAC.24.4.468

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  A collagenase digestion method for bioassay of antibiotics in ocular tissues.

Authors:  M Barza; A Kane; J Baum
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

2.  Monocyclic beta-lactam antibiotics produced by bacteria.

Authors:  R B Sykes; C M Cimarusti; D P Bonner; K Bush; D M Floyd; N H Georgopapadakou; W M Koster; W C Liu; W L Parker; P A Principe; M L Rathnum; W A Slusarchyk; W H Trejo; J S Wells
Journal:  Nature       Date:  1981-06-11       Impact factor: 49.962

3.  Radioactive and bioassay of intraocular antibiotics: double-assay technique to compare penicillin G, cefamandole, and gentamicin in ocular tissues in vivo.

Authors:  P Young; M Barza; A Kane; J Baum
Journal:  Arch Ophthalmol       Date:  1979-04

4.  Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution.

Authors:  A Kane; M Barza; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-05       Impact factor: 4.799

5.  The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor.

Authors:  M Barza; A Kane; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1982-06       Impact factor: 4.799

6.  The difficulty of determining the route of intraocular penetration of gentamicin after subconjunctival injection in the rabbit.

Authors:  M Barza; A Kane; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-04       Impact factor: 4.799

7.  Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis.

Authors:  A Kane; M Barza; J Baum
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

  7 in total
  12 in total

1.  Prediction of the vitreal half-life of small molecular drug-like compounds.

Authors:  Heidi Kidron; Eva M Del Amo; Kati-Sisko Vellonen; Arto Urtti
Journal:  Pharm Res       Date:  2012-07-10       Impact factor: 4.200

Review 2.  Testing retinal toxicity of drugs in animal models using electrophysiological and morphological techniques.

Authors:  Ido Perlman
Journal:  Doc Ophthalmol       Date:  2008-11-09       Impact factor: 2.379

Review 3.  Ocular drug delivery. Pharmacokinetic considerations.

Authors:  R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

4.  Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.

Authors:  S Kevin Li; Sarah A Molokhia; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 5.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of aztreonam.

Authors:  H Mattie
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

7.  Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).

Authors:  Chandrasekar Durairaj; Jaymin C Shah; Shruti Senapati; Uday B Kompella
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

8.  Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis.

Authors:  M A Smith; J A Sorenson; C Smith; M Miller; M Borenstein
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 9.  Pharmacokinetics of intravitreal antibiotics in endophthalmitis.

Authors:  Medikonda Radhika; Kopal Mithal; Abhishek Bawdekar; Vivek Dave; Animesh Jindal; Nidhi Relhan; Thomas Albini; Avinash Pathengay; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-09-10

10.  Permeability of the Retina and RPE-Choroid-Sclera to Three Ophthalmic Drugs and the Associated Factors.

Authors:  Hyeong Min Kim; Hyounkoo Han; Hye Kyoung Hong; Ji Hyun Park; Kyu Hyung Park; Hyuncheol Kim; Se Joon Woo
Journal:  Pharmaceutics       Date:  2021-05-04       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.